Literature DB >> 10359408

Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group .

M Lebech1, O Andersen, N C Christensen, J Hertel, H E Nielsen, B Peitersen, C Rechnitzer, S O Larsen, B Nørgaard-Pedersen, E Petersen.   

Abstract

BACKGROUND: The best method for prevention and control of congenital toxoplasma infection is uncertain. Prenatal screening is done in Austria and France, but the effect of treatment during pregnancy is not well documented. The aim of our study was to find out the maternofetal transmission rate and outcome in infants born to mothers who were not treated during pregnancy.
METHODS: We analysed 89873 eluates from phenylketonuria (PKU) cards from neonates and paired first-trimester serum samples from the mothers for specific IgG antibodies to Toxoplasma gondii. Children born to mothers who seroconverted during pregnancy were followed-up clinically and serologically to 12 months of age. In addition, 21144 PKU cards were analysed for toxoplasma-specific IgM antibodies during the last 12 months of the study.
FINDINGS: In 24989 (27.8%) cases both the PKU eluate and the first-trimester samples were IgG positive, which indicates previous maternal infection. 139 of the 64884 seronegative women acquired toxoplasma infection during pregnancy and gave birth to 141 infants (two sets of twins). 27 of these children were diagnosed with congenital toxoplasma infection. The transmission rate was 19.4% (95% CI 13.2-27.0). Clinical signs and symptoms were found in four (15%) of the 27 children. The additional analysis for toxoplasma-specific IgM antibodies from the PKU card identified seven of nine children with congenital toxoplasma infection. The false-positive rate for the IgM test was 0.19 per 1000, and no false-negatives were found.
INTERPRETATION: The risks of transmission of infection and of disease in the infant are low in an area with a low risk of toxoplasma infection. A neonatal screening programme based on detection of toxoplasma-specific IgM antibodies alone will identify between 70% and 80% of cases of congenital toxoplasmosis.

Entities:  

Mesh:

Year:  1999        PMID: 10359408     DOI: 10.1016/s0140-6736(98)11281-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  Is ocular toxoplasmosis caused by prenatal or postnatal infection?

Authors:  R E Gilbert; M R Stanford
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established.

Authors:  R Gilbert; C Dezateux
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

3.  Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies.

Authors:  M Paul; E Petersen; J Szczapa
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot.

Authors:  F Leslé; F Touafek; A Fekkar; D Mazier; L Paris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

5.  Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar.

Authors:  Marawan A Abu-Madi; Jerzy M Behnke; Haydee A Dabritz
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

6.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

7.  Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  V Rilling; K Dietz; D Krczal; F Knotek; G Enders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

Review 8.  Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature.

Authors:  Michael A Gaytant; G Ingrid J G Rours; Eric A P Steegers; Jochem M D Galama; Ben A Semmekrot
Journal:  Eur J Pediatr       Date:  2003-02-13       Impact factor: 3.183

9.  Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study.

Authors:  Mario Cortina-Borja; Hooi Kuan Tan; Martine Wallon; Malgorzata Paul; Andrea Prusa; Wilma Buffolano; Gunilla Malm; Alison Salt; Katherine Freeman; Eskild Petersen; Ruth E Gilbert
Journal:  PLoS Med       Date:  2010-10-12       Impact factor: 11.069

10.  A pilot study using residual newborn dried blood spots to assess the potential role of cytomegalovirus and Toxoplasma gondii in the etiology of congenital hydrocephalus.

Authors:  Regina M Simeone; Sonja A Rasmussen; Joanne V Mei; Sheila C Dollard; Jaime L Frias; Gary M Shaw; Mark A Canfield; Robert E Meyer; Jeffrey L Jones; Fred Lorey; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.